Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.01 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
2017Potential influences of complement factor H in autoimmune inflammatory and thrombotic disordersFerluga, J; Kouser, L; Murugaiah, V; Sim, RB; Kishore, U
2013Properdin and factor H: Opposing players on the alternative complement pathway "see-saw"Kouser, L; Abdul-Aziz, M; Nayak, A; Stover, CM; Sim, RB; Kishore, U
2016A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathwayKouser, L; Abdul-Aziz, M; Tsolaki, AG; Singhal, D; Schwaeble, WJ; Urban, BC; Khan, HA; Sim, RB; Kishore, U
24-May-2016Complement Factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine responseAbdul-Aziz, M; Tsolaki, A; Kouser, L; Carroll, MV; Al-Ahdal, MN; Sim, RB; Kishore, U
12-Feb-2018Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement ActivationKouser, L; Paudyal, B; Kaur, A; Stenbeck, G; Jones, LA; Abozaid, SM; Stover, CM; Flauhat, E; Sim, RB; Kishore, U
8-May-2018Human properdin modulates macrophage: Mycobacterium bovis BCG interaction via thrombospondin repeats (TSR) 4 and 5Al-Mozaini, M; Tsolaki, AG; Abdul-Aziz, M; Abozaid, SM; Al-Ahdal, MN; Pathan, AA; Murugaiah, V; Makarov, EM; Kaur, A; Sim, RB; Kishore, U; Kouser, L
30-Nov-2016Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune responsePondman, KM; Paudyal, B; Sim, RB; Kaur, A; Kouser, L; Tsolaki, AG; Jones, LA; Salvador-Morales, C; Khan, HA; ten Haken, B; Stenbeck, G; Kishore, U
5-Feb-2019Complement dependent and independent interaction between bovine conglutinin and Mycobacterium bovis BCG: implications in bovine tuberculosisMehamood, A; Kouser, L; Kaur, A; Holmskov, U; A-Ahdal, MN; Sim, RB; Kishore, U; Tsolaki, AG